NetworkNewsBreaks

ThursdaySep 21, 2017 9:19 am

NetworkNewsBreaks – InMed Pharmaceuticals, Inc. (CSE: IN) (OTCQB: IMLFF) Announces Inclusion in CSE25 Index

Preclinical stage biopharmaceutical company InMed Pharmaceuticals, Inc. (CSE: IN) (OTCQB: IMLFF) this morning announced that it has been included in the CSE25 Index after qualifying as one of the 25 largest companies in the CSE Composite Index. Per the update, the CSE25 Index is a subgroup of the CSE Composite Index, which was launched in 2015 and currently includes nearly half of the exchange’s listed companies and over 75 percent of the trading activity on the Canadian Securities Exchange. The CSE25 Index includes the top 25 securities contained within the CSE Composite Index based on market capitalization. According to the…

Continue Reading

WednesdaySep 20, 2017 2:37 pm

NetworkNewsBreaks – Top 10 Mid-day Percentage Gainers on September 20, 2017

Here is a list of stocks shaking up the markets today, with particular focus on NASDAQ and OTC small caps. The top gainers based on percentage: DMPI 87.60% – News: Receives U.S. patent regarding VAL-083 KPAY 23.02% – News: Reports record growth PPCB 17.39% – News: Provides shareholder update regarding PRP DRNA 14.78% – News: Participating in the LEERINK Partners Roundtable Series: Rare Disease and Immuno-Oncology on September 27 ISCO 12.42% – News: Advances toward phase 2 clinical trial in traumatic brain injury program ALT 7.92% – News: Receives FDA clearance to initiate phase 2 clinical study of NasoVAX SSC…

Continue Reading

WednesdaySep 20, 2017 2:37 pm

NetworkNewsBreaks – ROTH Capital Partners Names New Members of Healthcare Research Team

ROTH Capital Partners, a full service investment bank focused on serving emerging growth companies and their investors, this morning said that Jotin Marango, M.D., Ph.D. and Yasmeen Rahimi, Ph.D. have joined the firm’s healthcare research team. Dr. Marango joins ROTH from H.C. Wainwright & Co., where he covered hematology, oncology, and pulmonary therapeutics, with a specific focus on epigenetic and molecularly targeted therapies. Dr. Rahimi also joins ROTH from H.C. Wainwright & Co. Prior to her time at H.C. Wainwright & Co., she was a research associate at Guggenheim Securities. “Coupled with the recent additions to our healthcare banking team,…

Continue Reading

WednesdaySep 20, 2017 2:37 pm

NetworkNewsBreaks – HTG Molecular Diagnostics, Inc. (NASDAQ: HTGM) Strengthens IP Portfolio with Two New Method Patents Covering Technology

Shares of HTG Molecular Diagnostics, Inc. (NASDAQ: HTGM) are up 13% after the company this morning said it has been issued two new U.S. patents by the United States Patent and Trademark Office covering the company’s technology and applications of its technology. The first patent, entitled Molecular Malignancy in Melanocytic Lesions (U.S. Patent 9,758,829), was issued to HTG and the John Wayne Cancer Institute, who co-invented the technology. The patent claims a method of treatment on an indeterminate or atypical nevi that involves measuring the nucleic acid expression of certain biomarkers, including MAGEA2, PRAME, PDIA4, NR4A1, PDLIM7, B4GALT1, SAT1, RUNX1,…

Continue Reading

WednesdaySep 20, 2017 11:15 am

NetworkNewsBreaks – Terra Tech Corp. (TRTC) Signs Second Craft Cultivator to Grow Proprietary Cannabis Brand

Terra Tech Corp. (OTCQX: TRTC), a vertically integrated cannabis-focused agriculture company, recently announced a new farm partnership with a second Craft Cultivator to grow the company’s proprietary high grade “IVXX” cannabis flowers and oils. The farm, Cultivar Inc., located in Salinas, California, is approved for up to six acres (approximately 244,000 square feet) of cannabis cultivation in high tech, climate-controlled greenhouses. “We selected Cultivar to be our newest Cannabis Craftsman as it uses an all-natural cultivation methodology that upholds the high standards associated with our proprietary IVXX brand, including sustainable farming practices and the production of pesticide-free cannabis products,” Derek…

Continue Reading

WednesdaySep 20, 2017 11:12 am

NetworkNewsBreaks – Codan Limited (CODAF) Receives Increased Price Target from Independent Investment Research

Independent Investment Research has updated its coverage and increased its price target from $2.24 to $2.51 on shares of Codan Limited’s (OTC: CODAF) Australia-listed stock following the company’s report of financial results for the full year ending in 2017. The analyst noted that the company’s strong results for the year exceeded expectations, with an increase in revenues of 33.4% to $226.1 million. The growth in revenue is attributed primarily to new product development, which in turn enabled the company to pay down existing debt. The analyst noted that the constant development of new products continues to drive the company’s valuation.…

Continue Reading

WednesdaySep 20, 2017 11:07 am

NetworkNewsBreaks – Aerie Pharmaceuticals, Inc. (NASDAQ: AERI) Has “Buy” Rating Reiterated at Mizuho Securities

Mizuho Securities USA LLC has reiterated its ‘Buy’ rating and price target of $70 on shares of Aerie Pharmaceuticals, Inc.’s (NASDAQ: AERI) stock. The analyst noted the FDA’s recently reported date of the Advisory Committee for Aerie Pharmaceutical's Rhopressa to take place on October 13, 2017. This meeting is considered routine to take place before approval of a new product, specifically a new molecular entity. The analyst also noted another key date to remember in regards to the FDA meeting: October 11, the anticipated date that the FDA will release the background information on Rhopressa. This document typically offers a…

Continue Reading

WednesdaySep 20, 2017 9:14 am

NetworkNewsBreaks – ChineseInvestors.com, Inc. (CIIX) Director Featured in SmallCapVoice Interview

Market analysis company ChineseInvestors.com, Inc. (OTCQB: CIIX) this morning announced that its director of investor relations, Alan Klitenic, was featured in a recent interview with SmallCapVoice.com. In the interview, which can be heard at http://nnw.fm/flQB8, Klitenic discusses CIIX’s recent news, including updates related to the digital currency industry, the company’s plans to launch a Chinese daily video news broadcast from the NYSE floor, CIIX’s recent financial performance and its completion of the record filing process with the Chinese FDA related to its soon-to-be-launched hemp infused skin care line. “I want to emphatically state that CIIX is ready to make sales…

Continue Reading

TuesdaySep 19, 2017 12:08 pm

NetworkNewsBreaks – Top 10 Mid-day Percentage Gainers on September 19, 2017

Here is a list of stocks shaking up the markets today, with particular focus on NASDAQ and OTC small caps. The top gainers based on percentage: STAF 60.34% – News: Reports $40M in refinancing, closes two new acquisitions VSMR 18.48% – News: Completes The BP360 proximity marketing group acquisition ZPAS 10.00% – News: Provides company update MRMD 9.00% – News: Expands licensing agreement with Tikun Olam IWSY 6.42% – News: Obtains $11M in new funding XELB 4.92% – News: Law firm commences an investigation CLIR 4.86% – News: Completes first installation of The Duplex Plug and Play in Texas BKYI…

Continue Reading

TuesdaySep 19, 2017 12:07 pm

NetworkNewsBreaks – MassRoots, Inc. (MSRT) Plans to Expand Point of Sale System to Nevada Cannabis Market

MassRoots, Inc. (OTCQB: MSRT), one of the leading technology platforms for the cannabis industry, recently reported that it is expanding its point of sale system to the Nevada cannabis market. The decision by Nevada regulators to require all state-licensed cannabis businesses to file regulatory reports via Franwell, Inc.’s METRC system, replacing MJ Freeway’s Leaf Data Systems, effective November 1, 2017, presented MassRoots with an exciting growth opportunity, the company said in a news release. “We believe MassRoots is uniquely positioned to serve cannabis-related businesses in medical and recreational markets across the United States. We estimate our market-share of cannabis consumers…

Continue Reading